Notice of Changes to PA-19-083, "Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed)"
Notice NOT-AI-19-027 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 19, 2018 Category: Research Source Type: funding

Notice of Changes to PA-19-082, "Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed)"
Notice NOT-AI-19-026 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 19, 2018 Category: Research Source Type: funding

Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed)
Funding Opportunity PA-19-082 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support research activities that will contribute to the overall understanding of coccidioidomycosis, commonly known as Valley Fever, and other select endemic fungal diseases including histoplasmosis and blastomycosis. This research opportunity encourages studies that address diverse scientific areas such as: 1) pathogenesis; 2) host response; 3) disease transmission; 4) natural history and environmental factors contributing to disease; 5) vaccines; 6) diagnostics; and 7) therapeutics; wit...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 26, 2018 Category: Research Source Type: funding

Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed)
Funding Opportunity PA-19-083 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support research activities that will contribute to the overall understanding of coccidioidomycosis, commonly known as Valley Fever, and other select endemic fungal diseases including histoplasmosis and blastomycosis. This research opportunity encourages studies that address diverse scientific areas such as: 1) pathogenesis; 2) host response; 3) disease transmission; 4) natural history and environmental factors contributing to disease; 5) vaccines; 6) diagnostics; and 7) therapeutics; wit...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 26, 2018 Category: Research Source Type: funding

Call for Applications: Research Seed Money Grant for APS Type 1 (Autoimmune Polyglandular Syndrome Type 1)
National Organization for Rare Disorders (NORD), with APS Type 1.org, Announces Research Seed Money Grant (up to $100,000) for APS Type 1 (Autoimmune Polyglandular Syndrome Type 1) Abstract Submission Deadline:  July 10, 2014 NORD, with funding raised in coordination with the patient organization, , is accepting applications for a two-year grant, for a total of $100,000, to conduct a scientific and/or clinical research study related to APS Type 1. Also known as autoimmune polyglandular syndrome, type 1, APS Type 1 is a very rare hereditary disorder that strikes children and adults younger than 35 years of...
Source: ScanGrants feed - June 24, 2014 Category: Research Authors: National Organization for Rare Disorders/APS Type 1.Org Source Type: funding